Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s11864-021-00855-y http://scihub22266oqcxt.onion/10.1007/s11864-021-00855-y 34097148!8182729!34097148     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=34097148&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Curr+Treat+Options+Oncol 2021 ; 22 (7): 58 Nephropedia Template TP {{tp|p=34097148|t=2021. Cardio-oncology Training in the COVID-19 Era |pdf=|usr=}}{{34097148}} gab.com Text Cardio-oncology Training in the COVID-19 Era JO: Curr Treat Options Oncol http://www.kidney.de/pget.php?&tw=1&pmid=34097148 #FOAvip Cardio-oncology is a field dedicated to the prevention, diagnosis, and management of cardiovascular disease in cancer patients before, during, and after cancer therapy. It is an emerging field with limited opportunities for structured education and training. In the year 2021, we cannot define the requirements of cardio-oncology training without acknowledging the impact of the global coronavirus disease 19 (COVID-19) pandemic. While this pandemic poses significant health risks to patients with cancer and cardiovascular disease as well as the providers who care for them, it also allows novel opportunities for the nascent field of cardio-oncology to readily adapt. In this article, we detail how the COVID-19 pandemic has impacted all aspects of cardio-oncology training, how programs and trainees can adapt to these challenges, and how lessons learned from the COVID-19 era can continue to positively impact cardio-oncology training for the foreseeable future. Twit Text FOAVip Cardio-oncology Training in the COVID-19 Era ????Curr Treat Options Oncol http://www.kidney.de/pget.php?&tw=1&pmid=34097148 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34097148 #FOAvip English Wikipedia <ref>{{Cite pmid|34097148}}</ref> Cardio-oncology Training in the COVID-19 Era #MMPMID34097148 Feldman S; Liu J; Steingart R; Gupta D Curr Treat Options Oncol 2021[Jun]; 22 (7): 58 PMID34097148show ga Cardio-oncology is a field dedicated to the prevention, diagnosis, and management of cardiovascular disease in cancer patients before, during, and after cancer therapy. It is an emerging field with limited opportunities for structured education and training. In the year 2021, we cannot define the requirements of cardio-oncology training without acknowledging the impact of the global coronavirus disease 19 (COVID-19) pandemic. While this pandemic poses significant health risks to patients with cancer and cardiovascular disease as well as the providers who care for them, it also allows novel opportunities for the nascent field of cardio-oncology to readily adapt. In this article, we detail how the COVID-19 pandemic has impacted all aspects of cardio-oncology training, how programs and trainees can adapt to these challenges, and how lessons learned from the COVID-19 era can continue to positively impact cardio-oncology training for the foreseeable future. |COVID-19/*complications/virology[MESH] |Cardiovascular Diseases/chemically induced/complications/*prevention & control/virology[MESH] |Humans[MESH] |Medical Oncology/trends[MESH] |Neoplasms/complications/*drug therapy/pathology/virology[MESH]Cardio-oncology Training in the COVID-19 Era (epmc).pdf DeepDyve Pubget Overpricing